Defining lipid mediators of insulin resistance: controversies and challenges in: Journal of Molecular Endocrinology Volume 62 Issue 1 (2019)
Metabolic Messengers: ceramides | Nature Metabolism
The role of ceramides in metabolic disorders: when size and localization matters | Nature Reviews Endocrinology
ceramide hashtag on Twitter
Targeting Ceramide Synthesis to Reverse Insulin Resistance | Diabetes
Dynamic changes of muscle insulin sensitivity after metabolic surgery | Nature Communications
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
Ceramides as Novel Disease Biomarkers: Trends in Molecular Medicine
Podocyte lipotoxicity in diabetic kidney disease - Kidney International
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
Frontiers | Ceramides in Adipose Tissue | Endocrinology
Frontiers | The Role of Ceramides in Insulin Resistance | Endocrinology
PDF) SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
A review of the molecular pathways mediating the improvement in diabetes mellitus following caloric restriction - Yaribeygi - 2019 - Journal of Cellular Physiology - Wiley Online Library
Role of ceramides in the pathogenesis of diabetes mellitus and its complications - ScienceDirect
PDF) Interplay between ceramides and phytonutrients: New insights in metabolic syndrome
The role of sphingosine‐1‐phosphate in skeletal muscle: Physiology, mechanisms, and clinical perspectives - Cordeiro - 2019 - Journal of Cellular Physiology - Wiley Online Library
Genetic deletion of mast cell serotonin synthesis prevents the development of obesity and insulin resistance.,Nature Communications - X-MOL
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
Cardiomyopathy in obesity, insulin resistance and diabetes.,The Journal of Physiology - X-MOL
Mechanisms of insulin resistance related to white, beige, and brown adipocytes. - Abstract - Europe PMC
JLA :: Journal of Lipid and Atherosclerosis
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach. - Abstract - Europe PMC
Ceramide structure dictates glycosphingolipid nanodomain assembly and function | Nature Communications
